Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
2023 · Blood Cancer Journal · 18 citations
https://doi.org/10.1038/s41408-023-00882-y
A
Amanda Ciardiello
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
257
Citations
7
h-index
6
i10-index
Amanda Ciardiello is an academic researcher. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Garlic and Onion Studies. The author has an h-index of 7, co-authored 46 publications.
ORCID: 0000-0001-9463-8168Papers by this author
worksSupplementary Data TS1-4 from Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets
2024 · 0 citations
https://doi.org/10.1158/1078-0432.26517050
Supplementary fig 1 from Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets
2024 · 0 citations
https://doi.org/10.1158/1078-0432.26517044.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat